Abeona Therapeutics (ABEO) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to -$5.2 million.

  • Abeona Therapeutics' Profit After Tax rose 8294.96% to -$5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $82.4 million, marking a year-over-year increase of 21593.37%. This contributed to the annual value of -$63.7 million for FY2024, which is 1761.64% down from last year.
  • Per Abeona Therapeutics' latest filing, its Profit After Tax stood at -$5.2 million for Q3 2025, which was up 8294.96% from $108.8 million recorded in Q2 2025.
  • Abeona Therapeutics' Profit After Tax's 5-year high stood at $108.8 million during Q2 2025, with a 5-year trough of -$46.7 million in Q4 2021.
  • For the 5-year period, Abeona Therapeutics' Profit After Tax averaged around -$7.9 million, with its median value being -$11.8 million (2023).
  • Per our database at Business Quant, Abeona Therapeutics' Profit After Tax plummeted by 30649.26% in 2023 and then skyrocketed by 136952.47% in 2025.
  • Quarter analysis of 5 years shows Abeona Therapeutics' Profit After Tax stood at -$46.7 million in 2021, then surged by 84.75% to -$7.1 million in 2022, then plummeted by 132.99% to -$16.6 million in 2023, then surged by 43.99% to -$9.3 million in 2024, then surged by 44.46% to -$5.2 million in 2025.
  • Its Profit After Tax stands at -$5.2 million for Q3 2025, versus $108.8 million for Q2 2025 and -$12.0 million for Q1 2025.